Predictions for Future Federal Cannabis Laws
By Griffen Thorne, Attorney at Harris Bricken Most Americans favor federal cannabis legalization. Nearly all Americans support medical
Enveric Biosciences Loses $6.4 Million in Q2, Announces Cost-Reduction Plan
The company said it progressed toward obtaining federal patents on synthetic psychedelic drugs. Florida-based Enveric
Glass House Shrinks Losses to $25M in Q2 on Revenue Increase
Wholesale biomass sales for Glass House were up 358% year-over-year. California-based Glass House Brands (Cboe:
Clever Leaves Revenue Rises, Costs Fall in Q2
Clever Leaves Holdings Inc. (Nasdaq: CLVR) saw a 21% year-over-year rise for revenue in its
Michigan Cannabis Sales Break Another Record in July, Likely to Top $3B in 2023
Prices have also rebounded since January. This story was republished with permission from Crain’s Detroit Business and
Cybin Inches Closer to FDA Submission, Increases Losses in Q1
Toronto-based Cybin Inc. (NYSE: CYBN) (NEO: CYBN) increased its losses for its first fiscal quarter
MindMed Gets $50M Credit Line Boost
The company already drew $15 million. Clinical stage biopharmaceutical Mind Medicine Inc. (Nasdaq: MNMD) has
Block on new marijuana dispensaries in New York extended two weeks, at least. What to know
New cannabis dispensary licenses in New York are expected to remain temporarily on hold for
NAACP backs cannabis worker protections (Newsletter: August 14, 2023)
MN gov invites Iowans to try legal marijuana; AMA study: cannabis seen as safer than
A 15-Year Court Case Recently Came to an End for Maltese Cannabis Consumer
In the Mediterranean island of Malta, one man who was caught with cannabis 15 years